EDGAR Filing Documents for 0001104659-21-104595

Form 8-K - Current report:

SEC Accession No. 0001104659-21-104595

Filing Date

2021-08-13

Accepted

2021-08-13 07:00:12

Documents

Period of Report

2021-08-13

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2124654d1_8k.htm	8-K	19439
2	EXHIBIT 99.1	tm2124654d1_ex99-1.htm	EX-99.1	94947
	Complete submission text file	0001104659-21-104595.txt		115569

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39373 | Film No.: 211169673
SIC: 2834 Pharmaceutical Preparations